The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 15, 2018
Filed:
Apr. 16, 2015
Applicant:
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Inventors:
Michael McNevin, Doylestown, PA (US);
Sachin Lohani, Lansdale, PA (US);
Assignee:
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 249/06 (2006.01); C07D 413/14 (2006.01); A61K 31/551 (2006.01); C07C 305/04 (2006.01); C07C 309/04 (2006.01); C07C 309/30 (2006.01); C07C 305/06 (2006.01); C07C 309/66 (2006.01);
U.S. Cl.
CPC ...
C07D 413/14 (2013.01); A61K 31/551 (2013.01); C07C 305/04 (2013.01); C07C 305/06 (2013.01); C07C 309/04 (2013.01); C07C 309/30 (2013.01); C07C 309/66 (2013.01); C07B 2200/13 (2013.01);
Abstract
The invention is directed to pharmaceutically acceptable salts of suvorexant, which is an antagonist of orexin receptors. The pharmaceutically acceptable salts of suvorexant are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is further directed to pharmaceutical compositions comprising pharmaceutically acceptable salts of suvorexant.